News

Hims & Hers Health: Unlocking A $6 Billion Future
Hims & Hers Health reports 111% Q1 2025 revenue growth to $586M, driven by personalized treatments & strong margins. Read why ...
HIMS NOTICE: Hims & Hers Health, Inc. Shareholders Are Notified Of The Pending Class Action Lawsuit -- Contact BFA Law By August 25 Court Deadline (NYSE:HIMS)
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
WeightWatchers names new medical chief, plans to offer menopause therapy and support
WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women ...
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn't guaranteed
Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.
Even as prices drop, it's difficult to keep up with demand for new obesity drugs
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...